Lung cancer is the most common cause of cancer death worldwide, with a mortality that’s higher than colorectal, breast and prostate cancers combined. 13% of all new cancer cases diagnosed are lung cancer, and the number of lung cancer cases is only expected to grow.¹
Lung cancer screening has been shown to detect lung cancer at earlier stages when it is most curable. For that reason, lung cancer screening was recently approved for reimbursement by the Centers for Medicare and Medicaid Services (CMS) in the US. Hospitals there are now choosing the tools that can help them meet reimbursement requirements and track patients year after year while keeping their workflow streamlined.²
In Europe, clinical trials about lung cancer screening are still ongoing. Philips has one of the most comprehensive solution in the lung cancer screening space: scanners, image analysis tools and patient management.